Skip to main navigation Skip to search Skip to main content

The cost-utility of adjuvant chemotherapy using docetaxel and cyclophosphamide compared with doxorubicin and cyclophosphamide in breast cancer

Research output: Contribution to journal › Article › peer-review

27   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'The cost-utility of adjuvant chemotherapy using docetaxel and cyclophosphamide compared with doxorubicin and cyclophosphamide in breast cancer'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Keyphrases